Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Dow
Johnson and Johnson
Baxter
Moodys
AstraZeneca

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020934

See Plans and Pricing

« Back to Dashboard

NDA 020934 describes LUXIQ, which is a drug marketed by Mylan and is included in one NDA. It is available from two suppliers. Additional details are available on the LUXIQ profile page.

The generic ingredient in LUXIQ is betamethasone valerate. There are sixty-six drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 020934
Tradename:LUXIQ
Applicant:Mylan
Ingredient:betamethasone valerate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020934
Medical Subject Heading (MeSH) Categories for 020934
Suppliers and Packaging for NDA: 020934
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8180 0378-8180-50 50 g in 1 CAN (0378-8180-50)
LUXIQ betamethasone valerate AEROSOL, FOAM;TOPICAL 020934 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8180 0378-8180-99 100 g in 1 CAN (0378-8180-99)
Paragraph IV (Patent) Challenges for 020934
Tradename Dosage Ingredient NDA Submissiondate
LUXIQ AEROSOL, FOAM;TOPICAL betamethasone valerate 020934 2007-08-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.12%
Approval Date:Feb 28, 1999TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Express Scripts
Colorcon
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.